Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Editas Medicine (EDIT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,707,865
  • Shares Outstanding, K 47,270
  • Annual Sales, $ 13,730 K
  • Annual Income, $ -120,320 K
  • 36-Month Beta 3.77
  • Price/Sales 124.42
  • Price/Cash Flow N/A
  • Price/Book 6.89

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.02 +6.55%
on 06/28/18
41.43 -12.50%
on 06/21/18
-4.76 (-11.61%)
since 06/20/18
3-Month
31.12 +16.48%
on 04/30/18
41.43 -12.50%
on 06/21/18
+1.79 (+5.19%)
since 04/20/18
52-Week
15.28 +137.24%
on 07/27/17
45.02 -19.48%
on 03/09/18
+20.51 (+130.30%)
since 07/20/17

Most Recent Stories

More News
Free Technical Research on Edge Therapeutics and Three More Biotech Equities

Stock Research Monitor: CTMX, DVAX, and EDIT

CTMX : 24.40 (-0.45%)
DVAX : 15.75 (+0.64%)
EDIT : 36.25 (+0.33%)
EDGE : 1.00 (-1.96%)
Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year?

Is (EDIT) Outperforming Other Medical Stocks This Year?

EDIT : 36.25 (+0.33%)
Should You Invest in the ARK Genomic Revolution Multi-Sector ETF (ARKG)?

Sector ETF report for ARKG

ARKG : 31.24 (-0.48%)
ILMN : 311.15 (+0.66%)
EDIT : 36.25 (+0.33%)
NTLA : 31.62 (-0.03%)
August 10th Options Now Available For Editas Medicine (EDIT)

Investors in Editas Medicine Inc saw new options begin trading today, for the August 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EDIT options chain for...

EDIT : 36.25 (+0.33%)
Zacks Investment Ideas feature highlights: CRISPR, Editas and Intellia

Zacks Investment Ideas feature highlights: CRISPR, Editas and Intellia

CRSP : 58.35 (-0.07%)
EDIT : 36.25 (+0.33%)
NTLA : 31.62 (-0.03%)
Factors of Influence in 2018, Key Indicators and Opportunity within TrustCo Bank Corp NY, Highwoods Properties, Enova International, Editas Medicine, United Insurance, and Cutera -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of TrustCo Bank Corp NY (NASDAQ:TRST),...

ENVA : 38.25 (-0.13%)
HIW : 49.48 (-1.83%)
TRST : 9.05 (+1.12%)
UIHC : 20.31 (-0.05%)
EDIT : 36.25 (+0.33%)
CUTR : 43.50 (-0.11%)
CRISPR Science and Stocks: Knowing Enough to Invest

Can you learn enough about the science and the companies to invest with confidence?

SGMO : 15.10 (+0.33%)
CRSP : 58.35 (-0.07%)
EDIT : 36.25 (+0.33%)
GILD : 77.37 (+0.42%)
NTLA : 31.62 (-0.03%)
Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year?

Is Editas Medicine, Inc. (EDIT) Outperforming Other Medical Stocks This Year?

EDIT : 36.25 (+0.33%)
Editas Medicine to Participate in The JMP Securities Life Sciences Conference

Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will participate in a panel and host investor meetings at the JMP Securities Life Sciences Conference in New...

EDIT : 36.25 (+0.33%)
BIO Elects New Board Directors and Section Governing Board Chairs

The Biotechnology Innovation Organization (BIO) is pleased to announce the election of 11 new board directors and several new section governing board chairs and vice chairs at the 2018 ...

EDIT : 36.25 (+0.33%)
MON : 127.95 (+0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade EDIT with:

Business Summary

Editas Medicine, Inc. is a genome editing company. It focuses on translating its genome editing technology into a novel class of human therapeutics which enable precise and corrective molecular modification to treat diseases. Editas Medicine, Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 37.16
1st Resistance Point 36.71
Last Price 36.25
1st Support Level 35.79
2nd Support Level 35.33

See More

52-Week High 45.02
Last Price 36.25
Fibonacci 61.8% 33.66
Fibonacci 50% 30.15
Fibonacci 38.2% 26.64
52-Week Low 15.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar